Copenhagen, Capital Region of Denmark, Denmark
Physician-scientist and senior R&D leader with deep experience guiding complex scientific programs, shaping strategy, and building high-performing, cross-functional teams across biotech, pharma, and academia. I bring a strong track record in translational science and data-driven decision making across the full pharmaceutical value chain, from discovery through early clinical development. This breadth enables me to lead across scientific, strategic, and organizational dimensions to advance innovative therapies with real patient impact.
Interim C-level executive/independent advisor/consultant to Biotech and Specialty Pharma.
Advanced IL-22 program from lead selection to conclusion of Phase 2 trials in obesity and type 2 diabetes within five years while building a preclinical pipeline in metabolic and inflammatory diseases.
Provided matrix leadership on evidence generation to strengthen trial design and therapeutic positioning across Novo Nordisk’s trial portfolio.
Led 20+ scientists across Denmark and China to deliver genomics and bioinformatics insights for target and biomarker discovery across therapy areas, while scaling advanced data science capabilities across early R&D.
Provided academic oversight and leadership for the Centre’s educational and public engagement programs in genomics and personalised medicine, while managing its administrative team.
Conducted high-impact translational genomics research in islet biology and type 2 diabetes.